Education
About Us
Working with TipRanks
Follow Us
ADC Therapeutics Ltd (ADCT)
NYSE:ADCT
ADC Therapeutics (ADCT) Ownership Overview
32.84% Insiders
1.76% Mutual Funds
0.14% Other Institutional Investors
4.49% ETFs
60.77% Public Companies and
Individual Investors
The ownership structure of ADC Therapeutics (ADCT) stock is a mix of institutional, retail, and individual investors. Approximately 6.39% of the company’s stock is owned by Institutional Investors, 32.84% is owned by Insiders, and 60.77% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 13, 2024 | Redmile Group, Llc Director | xxxxxxxxxxxxx | $609000 |
| Dec 06, 2024 | Redmile Group, Llc Director | xxxxxxxxxxxxx | $52479 |
| Jul 03, 2024 | Redmile Group, Llc Director | xxxxxxxxxxxxx | $2248000 |
| Jun 18, 2024 | Robert Azelby Director | xxxxxxxxxxxxx | $20216 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $3208986 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $3848164 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 28,812,443 | Insider | 29.80% | 51,574,273 | |
| 3,494,738 | Institution | 3.61% | 6,255,581 | |
| 1,933,751 | Institution | 2.00% | 3,461,414 | |
| 1,612,556 | Institution | 1.67% | 2,886,475 | |
| 1,579,005 | Insider | 1.63% | 2,826,419 | |
| 901,722 | Institution | 0.93% | 1,614,082 | |
| 665,756 | Insider | 0.69% | 1,191,703 | |
| 541,892 | Insider | 0.56% | 969,987 | |
| 462,888 | Insider | 0.48% | 828,570 | |
| 451,973 | Institution | 0.47% | 809,032 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 901,722 | Institution | 0.93% | 1,614,082 | |
| 451,973 | Institution | 0.47% | 809,032 | |
| 194,258 | Institution | 0.20% | 347,722 | |
| 94,938 | Institution | 0.10% | 169,939 | |
| 34,126 | Institution | 0.04% | 61,086 | |
| 31,900 | Institution | 0.03% | 57,101 | |
| 28,588 | Institution | 0.03% | 51,173 | |
| 23,786 | Institution | 0.02% | 42,577 | |
| 22,226 | Institution | 0.02% | 39,785 | |
| 20,508 | Institution | 0.02% | 36,709 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,068,553 | Institution | 2.14% | 3,702,710 | |
| 471,342 | Institution | 0.49% | 843,702 | |
| 427,263 | Institution | 0.44% | 764,801 | |
| 370,403 | Institution | 0.38% | 651,909 | |
| 290,237 | Institution | 0.30% | 519,524 | |
| 181,760 | Institution | 0.19% | 325,350 | |
| 47,676 | Institution | 0.05% | 88,201 | |
| 46,833 | Institution | 0.05% | 86,641 | |
| 46,369 | Institution | 0.05% | 81,609 | |
| 29,913 | Institution | 0.03% | 53,544 |
FAQ
Who Owns ADC Therapeutics Ltd (ADCT)?
According to the latest TipRanks data, approximately 0.14% of the company's stock is held by institutional investors, 32.84% is held by insiders, and 60.77% is held by retail investors.
What percentage of ADC Therapeutics Ltd (ADCT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.14% of ADC Therapeutics Ltd (ADCT) stock is held by institutional investors.
What percentage of ADC Therapeutics Ltd (ADCT) stock is held by retail investors?
According to the latest TipRanks data, approximately 60.77% of ADC Therapeutics Ltd (ADCT) stock is held by retail investors.
Who owns the most shares of ADC Therapeutics Ltd (ADCT)?
Redmile Group, Llc owns the most shares of ADC Therapeutics Ltd (ADCT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.